Relationship of spinal dynorphin neurons to delta-opioid receptors and estrogen receptor alpha: anatomical basis for ovarian sex steroid opioid antinociception.
Pharmacological and behavioral studies suggest that spinal delta- and kappa-opioid antinociceptive systems are functionally associated with ovarian sex steroids. These interactions can be demonstrated specifically during pregnancy or hormone-simulated pregnancy (HSP). The analgesia associated with both conditions can be abolished by blockade of either spinal kappa-opioid receptors or delta-opioid receptors (DOR). Furthermore, both dynorphin (DYN) release (J Pharmacol Exp Ther 298:1213-1220, 2001) and the processing of the DYN precursor (J Neurochem 65:1374-1380, 1995) are significantly increased in the spinal cord during HSP. We undertook the current study to determine whether DYN, DOR, and estrogen receptor alpha (ERalpha) share anatomical relationships that permit their direct interaction. Coexpression of DOR or ERalpha by DYN neurons was assessed using fluorescence immunohistochemistry and a synaptosomal release assay. Findings show that ERalpha and DYN are coexpressed. Moreover, in the spinal cord of HSP animals, there were significant increases in the number of DYN-immunoreactive (DYN-ir) cells, ERalpha-ir cells, cells double-labeled for DYN-ir and ERalpha-ir and the proportion of DYN-ir cells coexpressing ERalpha. Some varicose fibers in the spinal cord dorsal horn and intermediate gray matter that expressed DYN-ir also expressed DOR-ir. Activation of DORs located on DYN terminals was sufficient to inhibit K(+)-evoked DYN release. These data define, at least in part, the anatomical substrates that may be relevant to the antinociception of gestation and its hormonal simulation. Furthermore, they provide a framework for understanding sex-based nociception and antinociception and suggest novel strategies for treating pain.
Department of Biochemistry, SUNY Downstate Medical Center, 450 Clarkson Ave, Brooklyn, NY 11203, USA. alan.gintzler@downstate.edu
Alan R
AR
Gintzler
Stephen A
SA
Schnell
Daya S
DS
Gupta
Nai-Jiang
NJ
Liu
Martin W
MW
Wessendorf
D000701:Analgesics, Opioid / Q000378:metabolism; D000818:Animals; D004399:Dynorphins / Q000032:analysis / Q000096:biosynthesis* / Q000235:genetics; D047628:Estrogen Receptor alpha / Q000032:analysis / Q000096:biosynthesis* / Q000235:genetics; D005260:Female; D012739:Gonadal Steroid Hormones / Q000096:biosynthesis* / Q000235:genetics; D009474:Neurons / Q000737:chemistry / Q000378:metabolism; D010053:Ovary / Q000033:anatomy & histology* / Q000737:chemistry / Q000378:metabolism*; D010146:Pain / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D011247:Pregnancy; D051381:Rats; D017207:Rats, Sprague-Dawley; D017465:Receptors, Opioid, delta / Q000032:analysis / Q000096:biosynthesis* / Q000235:genetics; D013116:Spinal Cord / Q000033:anatomy & histology* / Q000737:chemistry / Q000378:metabolism*
D000701:Analgesics, Opioid; D047628:Estrogen Receptor alpha; D012739:Gonadal Steroid Hormones; D017465:Receptors, Opioid, delta; D004399:Dynorphins